Skip to main content

Latest news

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Breaking headlines, in-depth features, hot topic review articles, and 

the latest from major international conferences brought to you by

Editors' pick

10-07-2018 | Gout | News

Hospitalization associated with increased gout flare risk

Admission to hospital is associated with a 10-fold increased risk for flare among patients with gout, study results suggest.


J Rheumatol 2018; doi:10.3899/jrheum.171320

Latest headlines

16-07-2018 | Pregnancy | News

TNF inhibitor discontinuation during pregnancy associated with increased flare risk

Women with inflammatory arthritis who discontinue tumor necrosis factor inhibitor therapy during pregnancy may be at increased risk for flare, researchers report.

13-07-2018 | Giant cell arteritis | News

Prolonged tocilizumab treatment needed to suppress GCA inflammation

An analysis of inflammatory markers suggests that patients with giant cell arteritis who are treated with tocilizumab still have subclinical disease activity during early remission, but not after 1 year of treatment.

12-07-2018 | Rheumatoid arthritis | News

Biologic DMARD refractory disease quantified in RA patients

At least 6% of patients who have ever received biologic DMARDs for rheumatoid arthritis will experience refractory disease, suggest UK study findings.

In depth

Transitioning from pediatric to adult rheumatology care

In this medwireNews podcast, we talk to Editorial Board member Sangeeta Sule about how patients with juvenile arthritis transition from pediatric to adult care, the challenges associated with this transition, and how the process can be improved.

Detecting and treating JIA-associated uveitis

The recently published SHARE recommendations provide guidance on screening, diagnosis, and treatment for JIA-associated uveitis. medwireNews looks at the key features of the guidelines, and talks to specialists about the impact they will have.

06-04-2018 | Spondyloarthropathies | Feature | Article

At a glance: Trials of tofacitinib in spondyloarthritis

A quick-reference guide to the published and ongoing clinical trials of tofacitinib for the treatment of spondyloarthritis.

image credits